UNIGE document Scientific Article
previous document  unige:9455  next document
add to browser collection

VIH – sida Traitement de l'infection à VIH en 2006 : points forts

Schiffer, V.
Published in Revue médicale suisse. 2007, vol. 3, no. 93, p. 69-74
Abstract In developed countries, drug therapy has turned HIV infection into a chronic disease. More is known about viral replication and new, easily tolerated drugs will enter the marketplace in 2007 and 2008. For the majority of patients who suffer neither resistance nor intolerance, older molecules are combined in the same pill. Very effective triple therapy, combining efavirenz, emtricitabine, and tenofovir in one pill (Atripla - Gilead) is already available in the United States and will become the standard of therapy in 2007. Since the eradication of the virus remains impossible even under effective antiretroviral therapy, the scheduled treatment interruptions as well as simplified maintenance therapies represent still a topic of interest for well selected patients, with an aim of reducing the costs and toxicities.
Keywords Anti-Retroviral Agents/ therapeutic useHIV Infections/ drug therapyHumans
PMID: 17354665
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
(ISO format)
SCHIFFER, V., HIRSCHEL, Bernard. VIH – sida Traitement de l'infection à VIH en 2006 : points forts. In: Revue médicale suisse, 2007, vol. 3, n° 93, p. 69-74. https://archive-ouverte.unige.ch/unige:9455

373 hits

0 download


Deposited on : 2010-07-12

Export document
Format :
Citation style :